Featured Story First Effective Treatment for Transthyretin Amyloidosis
Johns Hopkins research into rare disease leads to approval of the first drug that can halt its progression.
NeuroLogic Winter 2019
Articles in this Issue
-
Epilepsy Late in Life
Johns Hopkins neurologist led new study highlighting risk factors for seizures after age 60.
-
2 New Faculty Members Join the Department of Neurosurgery
The department welcomes Cameron McDougall, new director of endovascular neurosurgery, and neurosurgeon Debraj Mukherjee.
-
Understanding Neuromodulation
New gift will help researchers study basic and applied science behind this pain-relieving approach.
-
Improving Data for Alzheimer’s Disease
Johns Hopkins leads a new consortium to create a broader patient base for research. One target: early interventions.
